Drug
Creon
Creon: highest development phase Post-Market, developed by Abbott Laboratories. 1 trial record tracked on RxWires.
- Highest phase
- Post-Market
- Developer
- Abbott Laboratories
Trials
| Drug | Phase | Indication |
|---|---|---|
| Creon NCT02009410 | Post-Market | Exocrine Pancreatic Insufficiency in Subjects With Diabetes Mellitus Type 2 |
Latest
No recent events.
Follow Creon on RxWires to get trial status changes, FDA actions, filings and patent dates as they happen.
Sourced from ClinicalTrials.gov, openFDA, SEC EDGAR and the FDA Orange Book. Not investment or medical advice.